Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Neurology

Navigating Your Treatment Options

At a Glance

Treating Stiff Person Spectrum Disorder (SPSD) requires a dual-track approach: managing severe muscle stiffness with GABA-enhancing medications, and calming the underlying immune attack using immunotherapies like IVIG. Creating a medical crisis plan for severe spasms is also essential.

Treating Stiff Person Spectrum Disorder (SPSD) requires a dual-track strategy. One track focuses on silencing your overactive muscles (Symptom Management), while the other track works to calm the immune system that is attacking your nervous system (Immunotherapy) [1][2].

Track 1: Managing Your Symptoms

The immediate goal is to restore the “braking” signals your nervous system is missing.

  • GABA-Enhancers: The first line of defense is usually high-dose benzodiazepines (such as diazepam) or baclofen [3]. These medications help boost GABA, the chemical that tells your muscles to relax [4].
  • Intrathecal Baclofen Pumps: For severe stiffness that doesn’t respond to oral pills, some patients receive a pump that delivers baclofen directly into the spinal fluid, providing relief with fewer body-wide side effects [5].
  • Botulinum Toxin (Botox): If your stiffness is focused on a specific muscle group, injections can help “unfreeze” that area and reduce painful spasms [6].

Track 2: Calm the Immune Attack

While symptom management helps you feel better daily, immunotherapy addresses the underlying cause [1].

  • IVIG (Intravenous Immunoglobulin): This is considered a standard of care. It involves infusions of healthy antibodies from donors to neutralize the harmful autoantibodies in your system [7][8].
  • Plasmapheresis (TPE): Also known as “plasma exchange,” this procedure filters your blood to physically remove the antibodies causing the disease [9].
  • Rituximab: This is a more potent medication that targets and removes the specific immune cells (B-cells) that produce the harmful antibodies. It is often used when IVIG or plasma exchange isn’t enough [8][10].

The Crisis Plan: Managing Severe Spasms

Because SPSD spasms can be intensely painful and occasionally dangerous (leading to falls or bone fractures), you must have a Crisis Plan in place with your doctor [11].

  • Rescue Medications: Discuss whether you need rapid-acting muscle relaxants or anti-anxiety medications prescribed specifically for breaking severe spasms.
  • Emergency Protocols: Have a written letter from your neurologist explaining SPSD and detailing what medications emergency room doctors should administer. ER staff are often unfamiliar with the disease and may mistakenly treat it as a psychiatric event.
  • Family Action Plan: Ensure your family knows not to forcibly restrain you during a spasm, as this can cause injury, and to remove dangerous objects from the area.

Special Cases: Paraneoplastic SPSD

If your SPSD is linked to anti-amphiphysin antibodies, your treatment plan will have a critical third track: finding and treating an underlying cancer [12]. In many paraneoplastic cases, the immune system is actually trying to fight a tumor (often in the breast or lungs) and “misses,” hitting your nervous system instead [13]. Successfully treating or removing the tumor often leads to a dramatic improvement in SPSD symptoms [14].

Advanced Options: Resetting the System

For patients with severe SPSD that does not respond to standard treatments (“refractory” disease), more intensive options are being explored:

  • aHSCT (Autologous Hematopoietic Stem Cell Transplant): This is an intensive, investigational/experimental procedure that essentially “reboots” your immune system. It involves using chemotherapy to wipe out your malfunctioning immune system, then re-introducing your stem cells [15]. While effective for some, it is a major procedure with significant risks that is typically reserved for specialized centers and clinical trials [16].

Advocating for Comprehensive Care

Because SPSD is so rare, you may encounter doctors who only treat the symptoms (like giving you muscle relaxants) without addressing the autoimmune attack. Comprehensive care must include both tracks. If your doctor is only offering symptom relief and hasn’t discussed immunotherapy or antibody testing, it may be time to seek a specialist at a major academic medical center [1].

Common questions in this guide

How is Stiff Person Spectrum Disorder treated?
Treatment for SPSD typically involves a dual approach: managing daily symptoms like muscle stiffness and addressing the underlying immune system attack. This usually requires a combination of muscle relaxants and immunotherapy.
What medications help relieve SPSD muscle spasms?
GABA-enhancing medications like diazepam or baclofen are commonly used to help muscles relax. For severe stiffness, treatments like Botox injections or an intrathecal baclofen pump may also be recommended.
How does immunotherapy work for SPSD?
Immunotherapy aims to calm the immune system's attack on your nervous system. Treatments like Intravenous Immunoglobulin (IVIG), plasmapheresis, or Rituximab target and neutralize or remove the harmful antibodies causing the disease.
What should I do if I have a severe SPSD muscle spasm?
It is critical to establish a formal crisis plan with your doctor that includes specific rescue medications. You should also carry a letter from your neurologist explaining SPSD to emergency room staff, as they may be unfamiliar with how to safely treat the condition.
Can cancer cause Stiff Person Spectrum Disorder?
In some cases, SPSD can be paraneoplastic, meaning the immune system mistakenly attacks the nervous system while trying to fight an underlying tumor. If you test positive for anti-amphiphysin antibodies, your doctor will likely screen for cancer as part of your care.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Am I on the appropriate doses of GABA-enhancing medications like diazepam or baclofen before we consider my symptoms refractory?
  2. 2.If we start IVIG, how will we measure my response to the treatment, and how long should we wait before deciding if it's working?
  3. 3.What is our specific crisis plan if I experience an unyielding, severe spasm at home?
  4. 4.Is my specific antibody a reason to perform more frequent or specialized cancer screenings?
  5. 5.At what point should we discuss second-line immunotherapies like Rituximab or Plasmapheresis?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Muscle Stiffness due to Neuromuscular Hyperexcitability.

    Katirji B

    Muscle & nerve 2026; doi:10.1002/mus.70271.

    PMID: 42124386
  2. 2

    Pragmatic Treatment of Stiff Person Spectrum Disorders.

    Balint B, Meinck HM

    Movement disorders clinical practice 2018; (5(4)):394-401 doi:10.1002/mdc3.12629.

    PMID: 30363317
  3. 3

    Case Report: A case of influenza A infection-associated stiff person spectrum disorder with favorable outcome.

    Liu X, Lei M, Tian M, et al.

    Frontiers in immunology 2025; (16()):1673538 doi:10.3389/fimmu.2025.1673538.

    PMID: 41164193
  4. 4

    Stiff Person Syndrome.

    Saigal R, Goyal L, Yadav R, et al.

    The Journal of the Association of Physicians of India 2015; (63(8)):81-2.

    PMID: 27604442
  5. 5

    Successful Treatment of Stiff Person Syndrome with Intrathecal Baclofen.

    Geffen S, Chiang N

    Journal of rehabilitation medicine. Clinical communications 2019; (2()):1000016 doi:10.2340/20030711-1000016.

    PMID: 33884117
  6. 6

    Botulinum toxin as a potential adjunct therapy in stiff person syndrome spectrum disorders.

    Roman SN, Koshorek JL, Taylor ER, et al.

    Therapeutic advances in neurological disorders 2025; (18()):17562864251377182 doi:10.1177/17562864251377182.

    PMID: 41180121
  7. 7

    Updated consensus statement: Intravenous immunoglobulin in the treatment of neuromuscular disorders report of the AANEM ad hoc committee.

    Tavee J, Brannagan TH, Lenihan MW, et al.

    Muscle & nerve 2023; (68(4)):356-374 doi:10.1002/mus.27922.

    PMID: 37432872
  8. 8

    A double-blind, placebo-controlled study of rituximab in patients with stiff person syndrome.

    Dalakas MC, Rakocevic G, Dambrosia JM, et al.

    Annals of neurology 2017; (82(2)):271-277 doi:10.1002/ana.25002.

    PMID: 28749549
  9. 9

    Therapeutic plasma exchange in the management of stiff person syndrome spectrum disorders: a case series and review of the literature.

    Mercure-Corriveau N, Roy S, Hu C, et al.

    Therapeutic advances in neurological disorders 2023; (16()):17562864231180736 doi:10.1177/17562864231180736.

    PMID: 37529719
  10. 10

    Gastrointestinal and Urologic Sphincter Dysfunction in Stiff Person Syndrome.

    Dumitrascu OM, Tsimerinov EI, Lewis RA

    Journal of clinical neuromuscular disease 2016; (18(2)):92-95 doi:10.1097/CND.0000000000000143.

    PMID: 27861223
  11. 11

    [Stiff-Person Syndrome].

    Matsui N, Tanaka K, Izumi Y

    Brain and nerve = Shinkei kenkyu no shinpo 2023; (75(6)):749-754 doi:10.11477/mf.1416202410.

    PMID: 37287358
  12. 12

    Stiff-Person Syndrome with Anti-Amphiphysin Antibodies: A Paraneoplastic Phenomenon Revealing Breast Cancer in a 77-Year-Old Male.

    Geyskens M, Roos DS, Konings IR, et al.

    Case reports in neurology 2026; (18(1)):1-8 doi:10.1159/000549746.

    PMID: 41445546
  13. 13

    Case report of a woman with anti amphiphysin positive stiff person syndrome.

    Manhalter N, Györfi O, Boros E, et al.

    Ideggyogyaszati szemle 2017; (70(5-6)):213-216 doi:10.18071/isz.70.0213.

    PMID: 29870637
  14. 14

    Anti-glutamic acid decarboxylase 65: Related stiff person syndrome - A report of two cases and literature review.

    Naoe EEL, Durano RR, De Roxas-Bernardino RC, Saranza G

    SAGE open medical case reports 2025; (13()):2050313X251333676 doi:10.1177/2050313X251333676.

    PMID: 40308378
  15. 15

    Autologous haematopoietic stem cell transplantation for refractory stiff-person syndrome: the UK experience.

    Kass-Iliyya L, Snowden JA, Thorpe A, et al.

    Journal of neurology 2021; (268(1)):265-275 doi:10.1007/s00415-020-10054-8.

    PMID: 32785838
  16. 16

    Successful Autologous Hematopoietic Stem Cell Transplant in Glycine Receptor Antibody-Positive Stiff Person Syndrome: A Case Report

    Celli SI, Nash R, Money KM, et al.

    Neurology(R) neuroimmunology & neuroinflammation 2024; (11(2)):e200197 doi:10.1212/NXI.0000000000200197.

    PMID: 38170953

This page provides information on treatment options for Stiff Person Spectrum Disorder (SPSD) for educational purposes only. Always consult your neurologist or healthcare provider before making changes to your medication or treatment plan.

Get notified when new evidence is published on Stiff person spectrum disorder.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.